Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson's disease: implications for epigenetics-based nanotechnology-driven drug platform. [electronic resource]
Producer: 20150408ISSN:- 1553-3840
- Animals
- Animals, Genetically Modified
- Apoptosis -- drug effects
- Curcumin -- administration & dosage
- Disease Models, Animal
- Dopaminergic Neurons -- drug effects
- Exploratory Behavior -- drug effects
- Gene Knockout Techniques
- Histone Deacetylase Inhibitors -- administration & dosage
- Histone Deacetylases -- drug effects
- Nootropic Agents -- administration & dosage
- Parkinson Disease -- drug therapy
- Psychomotor Disorders -- drug therapy
- Random Allocation
- Rats
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.